Medicine and Dentistry
Patient
100%
Inpatient
85%
Infection
55%
Chronic Hepatitis C
50%
Therapeutic Procedure
42%
Antiviral Therapy
33%
Hepatitis C
32%
Genotype
31%
Antivirus Agent
28%
Hepatitis C Virus
27%
Liver Cirrhosis
23%
Liver Fibrosis
21%
Fibrosis
20%
Aspartate Aminotransferase
19%
Case Report
18%
Endoscopic Submucosal Dissection
18%
Stomach Cancer
18%
Nonalcoholic Fatty Liver
18%
Chronic Viral Hepatitis
18%
Rheumatoid Factor
18%
Sofosbuvir
17%
Retrospective Cohort Study
17%
Alanine Aminotransferase
16%
Serum
16%
Incidence
15%
Transaminase
15%
Analysis
15%
Platelet
14%
Bleeding
13%
Chronic Kidney Disease
13%
Hepatocellular Carcinoma
13%
Combination Therapy
12%
Surgery
12%
Neoplasm
12%
Age
11%
Fatty Liver
10%
Cohort Analysis
10%
Liver
10%
Biopsy
10%
Glomerular Filtration Rate
10%
Body Mass Index
10%
Virus RNA
10%
Ribavirin
10%
Acute on Chronic Liver Failure
9%
Child
9%
Ascites
9%
Measurement
9%
Cell Cycle
9%
Concurrent Infection
9%
Peptic Ulcer Bleeding
9%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis C
48%
Antivirus Agent
42%
Infection
39%
Glecaprevir Plus Pibrentasvir
37%
Sofosbuvir
36%
Hepatitis C Virus
34%
Chronic Hepatitis C
33%
Velpatasvir
27%
Cohort Study
23%
Liver Cirrhosis
20%
Aromatic Hydrocarbon Receptor
18%
Stomach Cancer
18%
Antiviral Therapy
18%
Incidence
17%
Fibrosis
17%
Adverse Event
14%
Ribavirin
11%
Survival
10%
Liver Fibrosis
10%
Ethanol
9%
Acute on Chronic Liver Failure
9%
Cell Death
9%
Quinazoline
9%
Superoxide Dismutase
9%
Sorafenib
9%
Brain Hemorrhage
9%
Carbendazim
9%
Ledipasvir Plus Sofosbuvir
9%
Resveratrol
9%
Anemia
9%
Cancer Growth
9%
Metastasis
9%
Esophagus Varices
9%
Rheumatoid Factor
9%
Hepatitis C Virus Genotype 2
9%
Helicobacter Pylori
9%
Fusobacterium nucleatum
9%
Hepatitis C
9%
Antivirus Agent
9%
Dexlansoprazole
9%
Pruritus
6%
RNA
5%
Bilirubin
5%
Virus
5%
Nursing and Health Professions
Hepatitis C
46%
Chronic Hepatitis C
42%
Patient
34%
Infection
29%
Liver Cirrhosis
20%
Combination Therapy
19%
Rheumatoid Factor
18%
Sofosbuvir
18%
Glecaprevir Plus Pibrentasvir
18%
Fibrosis
17%
Analysis
15%
Alanine Aminotransferase
12%
Aspartate Aminotransferase
11%
Antiviral Therapy
11%
Fatty Liver
10%
Liver Cell Carcinoma
10%
Cohort Analysis
10%
Liver Fibrosis
10%
Ribavirin
10%
Virus Load
10%
Acute on Chronic Liver Failure
9%
Incidence
9%
Ledipasvir Plus Sofosbuvir
9%
Cyclic Citrullinated Peptide Antibody
9%
Fetoprotein
9%
Estimated Glomerular Filtration Rate
9%
Prevalence
9%
Predictive Value
9%
Velpatasvir
9%
Nonalcoholic Fatty Liver
9%
Anemia
9%
Measurement
9%
Aminotransferase
9%
Blood Test
9%
Alpha Fetoprotein
9%
Intensive Care Unit
9%
Antiviral Therapy
9%
Body Mass
9%
Hepatitis C
9%
Odds Ratio
9%
Confidence Interval
7%
Antivirus Agent
7%
Sustained Virologic Response
6%
Antivirus Agent
5%
Adverse Event
5%
Hypertension
5%